| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. | Director | Ordinary Shares | 57.2K | $17.1M | $297.96 | Sep 5, 2025 | Direct |
| Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 15.3K | $574K | $37.39 | Jun 20, 2025 | Direct |
| BeOne Medicines Ltd. | Director | American Depositary Shares | 0 | $0 | $337.00 | Sep 5, 2025 | Direct |
| Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 10.8K | May 15, 2025 | Direct | ||
| Molecular Templates, Inc. | Director | Stock Option (right to buy) | 1K | Sep 27, 2024 | Direct | ||
| BeOne Medicines Ltd. | Director | Share Option (Right to Buy) | 0 | Sep 5, 2025 | Direct |